Izon Science isolates & analyses nano-biological particles. Its products are sold for medical R&D in 50 countries. A step change in the size of Izon’s business will be driven by one of its customers taking a product currently in testing to market – such as a cancer test. Izon has 50 staff in NZ, the USA & France. Hans talks about funding a company when it’s cash negative, getting focused on marketing and continuing to innovate to find the product-market fit. 

www.izon.com